ResMed Announces Participation in the KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum
SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight